The association between interleukin-10 (IL-10) -592C/A, -819T/C, -1082G/A promoter polymorphisms and endometriosis

other OA: closed public-domain-us
Full text JSON View on PubMed View at publisher
AI-generated summary by claude@2026-06, 2026-06-08

This study found higher serum IL-10 levels and associations between IL-10 promoter polymorphisms at positions -592 and -819 and susceptibility to advanced endometriosis.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

Abstract

PURPOSE: Endometriosis has an incidence reaching up to 50% in infertile women. Cytokine-mediated immune responses seem to play an important role in endometriosis pathogenesis, but still the etiology and pathophysiology remain unclear. In the current study we tried to investigate whether there is a relationship between IL-10 genetic polymorphism, serum levels of IL-10 and the presence of advanced endometriosis. METHODS: The presence of IL-10 592C/A, 819T/C, 1082G/A promoter polymorphisms and IL-10 serum levels were investigated in advanced endometriosis patients compared to healthy controls. Genomic DNA was extracted from peripheral blood leukocytes and further analyzed by PCR. RESULTS: IL-10 serum levels were higher in endometriosis group compared to controls (1.48, 0.68, p < 0.001). We have observed an association between IL-10 592C/C and 819C/C genotypes, presence of C alleles and an increased risk of endometriosis. No difference was observed in IL-10 serum levels corresponding to different alleles or genotypes. CONCLUSION: Our results suggest that IL-10 592A/C and 819T/C promoter polymorphisms confer susceptibility to advanced endometriosis. No associations were found between the IL-10 1082A/G polymorphism and susceptibility to advanced endometriosis.
Full text 9,166 characters · extracted from oa-doi-fallback · 6 sections · click to expand

Abstract

Purpose Endometriosis has an incidence reaching up to 50% in infertile women. Cytokine-mediated immune responses seem to play an important role in endometriosis pathogenesis, but still the etiology and pathophysiology remain unclear. In the current study we tried to investigate whether there is a relationship between IL-10 genetic polymorphism, serum levels of IL-10 and the presence of advanced endometriosis.

Methods

The presence of IL-10 592C/A, 819T/C, 1082G/A promoter polymorphisms and IL-10 serum levels were investigated in advanced endometriosis patients compared to healthy controls. Genomic DNA was extracted from peripheral blood leukocytes and further analyzed by PCR.

Results

IL-10 serum levels were higher in endometriosis group compared to controls (1.48, 0.68, p < 0.001). We have observed an association between IL-10 592C/C and 819C/C genotypes, presence of C alleles and an increased risk of endometriosis. No difference was observed in IL-10 serum levels corresponding to different alleles or genotypes.

Conclusion

Our results suggest that IL-10 592A/C and 819T/C promoter polymorphisms confer susceptibility to advanced endometriosis. No associations were found between the IL-10 1082A/G polymorphism and susceptibility to advanced endometriosis. Similar content being viewed by others

References

Kvaskoff M, Mu F, Terry KL, Harris HR, Poole EM, Farland L et al (2015) Endometriosis: a high-risk population for major chronic diseases? Hum Reprod Update 21(4):500–516 Tempfer CB, Simoni M, Destenaves B, Fauser BC (2009) Functional genetic polymorphisms and female reproductive disorders: part II–endometriosis. Hum Reprod Update 15(1):97–118 Buggio L, Pagliardini L, Gentilini D, De Braud L, Viganò P, Vercellini P (2014) A rare familial case of endometriosis with very severe gynecological and obstetric complications: novel genetic variants at a glance. Gynecol Obstet Investig 77(3):201–204 Podgaec S, Abrao MS, Dias JA Jr, Rizzo LV, de Oliveira RM, Baracat EC (2007) Endometriosis: an inflammatory disease with a Th2 immune response component. Hum Reprod 22(5):1373–1379 Gallegos-Arreola MP, Figuera-Villanueva LE, Puebla-Pérez AM, Montoya-Fuentes H, Suarez-Rincon AE, Zúñiga-González GM (2012) Association of TP53 gene codon 72 polymorphism with endometriosis in Mexican women. Genet Mol Res 11(2):1401–1408 Chun S, Kim H, Ku SY, Suh CS, Kim SH, Kim JG (2012) The association between endometriosis and polymorphisms in the interleukin-1 family genes in Korean women. Am J Reprod Immunol 68(2):154–163 Kyama CM, Mihalyi A, Simsa P, Falconer H, Fulop V, Mwenda JM et al (2009) Role of cytokines in the endometrial-peritoneal cross-talk and development of endometriosis. Front Biosci (Elite Ed) 1:444–454 Gallagher PM, Lowe G, Fitzgerald T, Bella A, Greene CM, McElvaney NG et al (2003) Association of IL-10 polymorphism with severity of illness in community acquired pneumonia. Thorax 58:154–156 Núñez C, Alecsandru D, Varadé J, Polanco I, Maluenda C, Fernández-Arquero M et al (2006) Interleukin-10 haplotypes in celiac disease in the Spanish population. BMC Med Genet 7:32–36 Mier-Cabrera J, Jiménez-Zamudio L, García-Latorre E, Cruz-Orozco O, Hernández-Guerrero C (2011) Quantitative and qualitative peritoneal immune profiles, T-cell apoptosis and oxidative stress-associated characteristics in women with minimal and mild endometriosis. BJOG 118(1):6–16 Monsanto SP, Edwards AK, Zhou J, Nagarkatti P, Nagarkatti M, Young SL et al (2016) Surgical removal of endometriotic lesions alters local and systemic proinflammatory cytokines in endometriosis patients. Fertil Steril 105(4):968–977 Hassa H, Tanir HM, Tekin B, Kirilmaz SD, Sahin Mutlu F (2009) Cytokine and immune cell levels in peritoneal fluid and peripheral blood of women with early- and late-staged endometriosis. Arch Gynecol Obstet 279(6):891–895 Auguet T, Vidal F, Broch M, Olona M, Aguilar C, Morancho B et al (2010) Polymorphisms in the interleukin-10 gene promoter and the risk of alcoholism and alcoholic liver disease in Caucasian Spaniard men. Alcohol 44(3):211–216 Paradowska-Gorycka A, Trefler J, Maciejewska-Stelmach J, Łacki JK (2010) Interleukin-10 gene promoter polymorphism in Polish rheumatoid arthritis patients. Int J Immunogenet 37(4):225–231 Peng Z, Lv X, Sun Y, Dai S (2016) Association of interleukin-10-1082A/G polymorphism with idiopathic recurrent miscarriage: a systematic review and meta-analysis. Am J Reprod Immunol 75(2):162–171 He P, Zhang XM, Deng L, Ma JY (2009) Relationship between IL-10 promoter gene polymorphisms and the susceptibility to endometriosis. Yi Chuan 31(5):479–484 Zhang X, Hei P, Deng L, Lin J (2007) Interleukin-10 gene promoter polymorphisms and their protein production in peritoneal fluid in patients with endometriosis. Mol Hum Reprod 13(2):135–140 Fan W, Li S, Chen Q, Huang Z, Ma Q, Xiao Z (2013) Association between interleukin-10 promoter polymorphisms and endometriosis: a meta-analysis. Gene 515(1):49–55 Riiskjaer M, Nielsen K, Steffensen R, Erikstrup C, Forman A, Kruse C (2011) Association of interleukin-10 promoter polymorphism and endometriosis. Am J Reprod Immunol 65(1):13–19 Laganà AS, Triolo O, Salmeri FM, Granese R, Palmara VI, Ban Frangež H et al (2016) Natural killer T cell subsets in eutopic and ectopic endometrium: a fresh look to a busy corner. Arch Gynecol Obstet 293(5):941–949 Fairbanks F, Abrão MS, Podgaec S, Dias JA Jr, de Oliveira RM, Rizzo LV (2009) Interleukin-12 but not interleukin-18 is associated with severe endometriosis. Fertil Steril 91(2):320–324 Podgaec S, Dias Junior JA, Chapron C, Oliveira RM, Baracat EC, Abrão MS (2010) Th1 and Th2 immune responses related to pelvic endometriosis. Rev Assoc Med Bras 56(1):92–98 Neves F, Abrantes J, Almeida T, de Matos AL, Costa PP, Esteves PJ (2015) Genetic characterization of interleukins (IL-1α, IL-1β, IL-2, IL-4, IL-8, IL-10, IL-12A, IL-12B, IL-15 and IL-18) with relevant biological roles in lagomorphs. Innate Immun 21(8):787–801 Karimabad MN, Arababadi MK, Hakimizadeh E, Daredori HY, Nazari M, Hassanshahi G et al (2013) Is the IL-10 promoter polymorphism at position -592 associated with immune system-related diseases? Inflammation 36(1):35–41 Trifunović J, Miller L, Debeljak Ž, Horvat V (2015) Pathologic patterns of interleukin 10 expression-a review. Biochem Med (Zagreb) 5(1):36–48 Suen JL, Chang Y, Chiu PR, Hsieh TH, Hsi E, Chen YC et al (2014) Serum level of IL-10 is increased in patients with endometriosis, and IL-10 promotes the growth of lesions in a murine model. Am J Pathol 184(2):464–471 Opdal SH (2004) IL-10 gene polymorphisms in infectious disease and SIDS. FEMS Immunol Med Microbiol 42(1):48–52 Wickiewicz D, Chrobak A, Gmyrek GB, Halbersztadt A, Gabryś MS, Goluda M et al (2013) Diagnostic accuracy of interleukin-6 levels in peritoneal fluid for detection of endometriosis. Arch Gynecol Obstet 288(4):805–814 Măluţan AM, Drugan T, Ciortea R, Mocan-Hognogi RF, Bucuri C, Rada MP et al (2015) Serum anti-inflammatory cytokines for the evaluation of inflammatory status in endometriosis. J Res Med Sci 20(7):668–674 Pawlik A, Kurzawski M, Szklarz BG, Herczynska M, Drozdzik M et al (2005) Interleukin-10 promoter polymorphism in patients with rheumatoid arthritis. Clin Rheumatol 24(5):480–484 Persico M, Capasso M, Persico E, Masarone M, Renzo A, Spano D et al (2006) Interleukin-10-1082 GG polymorphism influences the occurrence and the clinical characteristics of hepatitis C virus infection. J Hepatol 45:779–785 Swiątek BJ (2012) Is interleukin-10 gene polymorphism a predictive marker in HCV infection? Cytokine Growth Factor Rev. 23(1–2):47–59

Acknowledgements

This paper was published under the project funded by “Iuliu Hatieganu” University of Medicine and Pharmacy, Cluj-Napoca, Romania, internal Grant No. 4945/20/08.03.2016. Author information Authors and Affiliations Corresponding author Ethics declarations Funding This study was funded by “Iuliu Hatieganu” University of Medicine and Pharmacy, Cluj-Napoca, Romania, internal Grant No. 4945/20/08.03.2016. Conflict of interest A.M. Malutan declares that he has no conflict of interest. C. Drugan declares that she has no conflict of interest. K. Walch declares that she has no conflict of interest. T. Drugan declares that he has no conflict of interest. R. Ciortea declares that he has no conflict of interest. D. Mihu declares that he has no conflict of interest. Ethical approval All procedures performed in this study involving were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards. Informed consent Informed consent was obtained from all individual participants included in the study. Rights and permissions About this article Cite this article Malutan, A.M., Drugan, C., Walch, K. et al. The association between interleukin-10 (IL-10) −592C/A, −819T/C, −1082G/A promoter polymorphisms and endometriosis. Arch Gynecol Obstet 295, 503–510 (2017). https://doi.org/10.1007/s00404-016-4269-5 Received: Accepted: Published: Issue date: DOI: https://doi.org/10.1007/s00404-016-4269-5

Text is read by the "Ask this paper" AI Q&A widget below. Extraction quality varies by source — PMC NXML preserves structure cleanly, OA-HTML may include some navigation residue, and OA-PDF can have broken hyphenation. The publisher copy (via DOI) is the canonical version.

My notes (saved in your browser only)

Ask this paper AI returns verbatim quotes from the full text · source: oa-doi-fallback

Answers must be backed by verbatim quotes from this paper's full text. Hallucinated quotes are dropped automatically; if no verbatim passage answers the question, we say so. How this works

Condition tags

endometriosis

MeSH descriptors

Endometriosis Genetic Predisposition to Disease Interleukin-10 Polymorphism, Genetic Promoter Regions, Genetic Adult Case-Control Studies Endometriosis Endometriosis Female Genotype Humans Interleukin-10 Interleukin-10 Middle Aged

Funding

funders
[{'doi': None, 'name': 'Universitatea de Medicina si Farmacie "Iuliu Hatieganu" Cluj-Napoca, Romania (RO)', 'awards': ['4945/20/08.03.2016']}]

Citation neighborhood

Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.

References (32)

Source provenance

crossref
last seen: 2026-05-18T01:00:41.687743+00:00
europepmc
last seen: 2026-06-11T06:19:48.454388+00:00
pubmed
last seen: 2026-05-13T22:20:37.704673+00:00
unpaywall
last seen: 2026-06-02T02:00:03.124865+00:00
License: public-domain-us · commercial use OK · attribution required
Courtesy of the U.S. National Library of Medicine